HAIXI PHARMA will delay its market launch

智通財經
2025.10.16 13:29

智通財經 APP 訊，海西新藥公佈，因需要額外時間完成配發結果公告的定稿及獲取監管機構批准，公司的上市時間表將會順延。董事會將在切實可行情況下儘快向市場提供最新資料。

智通財經 APP 訊，海西新藥 (02637) 公佈，因需要額外時間完成配發結果公告的定稿及獲取監管機構批准，公司的上市時間表將會順延。董事會將在切實可行情況下儘快向市場提供最新資料。

Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.